Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY – Get Free Report) hit a new 52-week low during trading on Wednesday . The company traded as low as $12.56 and last traded at $12.56, with a volume of 501 shares changing hands. The stock had previously closed at $15.5640.
Ambu A/S Stock Down 16.5%
The company has a market capitalization of $2.95 billion, a price-to-earnings ratio of 66.11 and a beta of 0.85. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.73 and a current ratio of 2.90. The firm’s 50-day simple moving average is $15.76 and its 200-day simple moving average is $15.52.
Ambu A/S (OTCMKTS:AMBBY – Get Free Report) last announced its quarterly earnings data on Wednesday, November 5th. The company reported $0.07 EPS for the quarter. Ambu A/S had a return on equity of 6.11% and a net margin of 5.93%.
Ambu A/S Company Profile
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
See Also
- Five stocks we like better than Ambu A/S
- Insider Trading – What You Need to Know
- Stardust’s Strategic Lithium Deal Could Be a Game-Changer
- How to Use the MarketBeat Excel Dividend Calculator
- Sticker Shock: Why Kimberly-Clark’s Sell-Off Is an Overreaction
- What is a Low P/E Ratio and What Does it Tell Investors?
- Why Hims & Hers Stock May Be a Buy After Mixed Q3 Results
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.
